Skip to main content
White paper

Part D redesign under the Inflation Reduction Act

Potential financial ramifications for Part D plans and pharmaceutical manufacturers

By Corey Berger, Tyler Engel, and Todd Wanta
30 August 2023

About the Author(s)

We’re here to help

Ask the tough questions. We’re ready for them.

popup image